BRAF and thyroid cancer: A genomic study performed in a large cohort of PTC from Saudi Arabia (n = 886), where thyroid cancer is the second most common cancer in women, showed a high prevalence of BRAF (59%), HRAS (2%), and NRAS (1%), similar to other cohorts.